BIONTECH

The latest health bulletin from the National Public Health Organization (NPHO) covers a variety of health topics, featuring questions about vaccinations directed to the Chair of the National Vaccination Committee, Professor Emerita of Pediatrics at the National and Kapodistrian University of Athens, Maria Theodoridou, along with her responses.

Albert Bourla linked Pfizer‘s name with the containment effort of the COVID-19 pandemic and this is the piece of history that belongs to him definitively, objectively and beyond any objection or reservation.

This vaccine, known as BNT116 and developed by BioNTech, targets non-small cell lung cancer (NSCLC), the most common type of lung cancer. Its aim is to eliminate cancer cells and prevent their recurrence by training the immune system to recognize and attack these cancerous cells.

Turkish scientists Uğur Şahin and Özlem Türeci, the co-founders of BioNTech, have announced that their cancer vaccine has succeeded in halting tumor growth and reducing its size in their initial tests.

EU regulators have recommended authorizing an updated Covid-19 vaccine from Pfizer and its German partner BioNTech which targets the dominant XBB.1.5 variant of Omicron, putting it on track to become the third adapted shot  by the two companies to be approved in the bloc.

Uğur Şahin, one of BioNTech's co-founders, has announced that their company's cancer treatment medicine will hit the shelves as early as 2026.

Şahin, who has been working with his wife Dr. Özlem Türeci for many years on treatments targeting various types of cancers, especially bowel cancer, stated that the drugs they have developed could be on the market in a few years.

Pharmaceutical giant Pfizer said it plans a cost-cutting operation if its co-developed with BioTech COVID-19 vaccine and antiviral treatment for the coronavirus continue to underperform in the coming months due to falling demand.

Following a large-scale study conducted on the COVID-19 vaccine effectiveness in Türkiye, experts have stressed that some 58 percent of individuals who developed serious illnesses were unvaccinated.

The results of one of the largest studies in the country showing the effectiveness of the COVID-19 vaccine were announced.

Alamy Photo

Germany-based biotechnology company BioNTech and Türkiye's Koç University have signed a collaboration agreement that encompasses a series of clinical research, mainly cancer treatments.

US pharmaceutical company Pfizer has agreed to extend its contract with the European Union for the vaccine against COVID-19 from 2023 to 2026, the Financial Times reported, citing sources familiar with the matter.